The Patent Finder

Medeva Pharma Schweiz AG

Also on record
Records under this name other than patents Medeva Pharma Schweiz AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 4 of 4 · Back to Medeva Pharma Schweiz AG

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 5,541,170Orally administrable pharmaceutical compositions
Formerly held
Term ended
Term ended no later than Jul 30, 2016 · Low confidence
Term endedTerm ended no later than Jul 30, 2016Low confidence
US 5,541,171Orally administrable pharmaceutical composition
Formerly held
Term ended
Term ended no later than Jul 30, 2016 · Low confidence
Term endedTerm ended no later than Jul 30, 2016Low confidence
US 5,792,795Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids
Formerly held
Term ended
Term ended no later than Aug 11, 2018 · Low confidence
Term endedTerm ended no later than Aug 11, 2018Low confidence
US 5,948,818Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids
Formerly held
Term ended
Term ended no later than Sep 7, 2019 · Low confidence
Term endedTerm ended no later than Sep 7, 2019Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited